US Broker Ratings

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology

Alpha Tau Medical Ltd. (NASDAQ: DRTS), headquartered in Jerusalem, Israel, is a burgeoning name in the biotechnology sector, specifically in the oncology therapeutics industry. With a market capitalization of approximately..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring the 127.64% Upside Potential in the Medical Device Sector

Senseonics Holdings, Inc. (NASDAQ: SENS) has captured the attention of investors with its innovative approach to diabetes management and a compelling growth narrative. As a commercial-stage medical technology company, Senseonics..

ReposiTrak, Inc. (TRAK) Stock Analysis: An 87.79% Upside Potential for Investors

ReposiTrak, Inc. (TRAK), an innovative player in the technology sector, operates at the intersection of software applications and supply chain management. With a focus on compliance and traceability, the company..

Benitec Biopharma Inc. (BNTC)

⚠️ No article content returned.

..

AppLovin Corporation (APP) Stock Analysis: Unveiling a 56.91% Potential Upside

AppLovin Corporation (NASDAQ: APP), a notable player in the Communication Services sector, operates within the dynamic landscape of advertising agencies. With a market capitalization of $142.64 billion, AppLovin stands as..

Kaltura, Inc. (KLTR) Stock Analysis: Unpacking the 167% Potential Upside

Investors with an eye for technological innovation might want to take a closer look at Kaltura, Inc. (NASDAQ: KLTR), a notable player in the software-as-a-service (SaaS) and platform-as-a-service (PaaS) sectors...

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Look at Its 85.88% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is stirring up interest among investors, particularly within the ever-evolving biotechnology sector. Headquartered in Florham Park, New Jersey, this innovative biopharmaceutical company is focused on..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: A Biotech Contender with Nearly 80% Upside Potential

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) presents a compelling opportunity for investors seeking exposure to the biotechnology sector. With a market capitalization of $489.41 million, Vanda is a U.S.-based biopharmaceutical company..

Chevron Corporation (CVX) Investor Outlook: A Comprehensive Evaluation of Its Market Position and Dividend Potential

Chevron Corporation (NYSE: CVX), a stalwart in the integrated oil and gas industry, stands as one of the largest players in the energy sector, boasting a market capitalization of $368.32..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Unveiling a 259% Potential Upside in Biotech

Candel Therapeutics, Inc. (NASDAQ: CADL), a burgeoning player in the biotechnology sector, is drawing attention from investors with its innovative approach to cancer treatment and a remarkable potential upside of..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Exploring a 51.54% Potential Upside with Strategic Market Intelligence

ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a pivotal player in the technology sector, particularly within the application software industry. Known for its advanced go-to-market intelligence platform, ZoomInfo caters to..

Erasca, Inc. (ERAS) Stock Analysis: Unlocking Potential in Precision Oncology with a Robust Pipeline

Erasca, Inc. (NASDAQ: ERAS) stands at the forefront of precision oncology, focusing on the discovery and development of therapies targeting RAS/MAPK pathway-driven cancers. With a market capitalization of $4.17 billion,..

Asure Software Inc (ASUR) Stock Analysis: A Potential 78% Upside with Strong Buy Ratings

Asure Software Inc (NASDAQ: ASUR), a key player in the cloud-based Human Capital Management (HCM) software sector, has captured investor attention with its compelling growth prospects and a potential 78.20%..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating the Challenges with a 52-Week Range Anomaly

NetClass Technology Inc (NTCL), a Singapore-based player in the Technology sector, specifically within the Software – Application industry, has captured attention due to its intriguing 52-week price range of $0.25..

Materialise NV (MTLS) Stock Analysis: Unpacking a 65.88% Potential Upside in the 3D Printing Arena

Materialise NV (NASDAQ: MTLS) is carving its niche in the dynamic world of 3D printing and additive manufacturing. Headquartered in Leuven, Belgium, this technology company is a prominent player within..

Sanara MedTech Inc. (SMTI) Investor Outlook: Exploring a Potential 101% Upside

Sanara MedTech Inc. (NASDAQ: SMTI) is positioning itself as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of approximately..

CytomX Therapeutics, Inc. (CTMX): Investor Outlook Reveals 55.71% Potential Upside

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is emerging as a compelling player in the biotechnology sector with a strong focus on oncology. Operating out of South San Francisco, California, the company..

Neuronetics, Inc. (STIM) Stock Analysis: A Compelling 385% Upside Potential Awaits Investors

Neuronetics, Inc. (NASDAQ: STIM), a healthcare company recognized for its innovative medical devices, is garnering significant attention from investors, thanks to its remarkable upside potential. With a market capitalization of..

Neurogene Inc. (NGNE) Stock Analysis: Exploring a Potential 184.72% Upside in the Biotech Sector

Neurogene Inc. (NGNE), a pioneering player in the biotechnology sector, is attracting attention from investors due to its promising pipeline of genetic medicines targeting rare neurological disorders. With a current..

Grab Holdings Limited (GRAB) Stock Analysis: A Potential 55% Upside in the Superapp Revolution

Grab Holdings Limited (NASDAQ: GRAB), a leading player in the technology sector, is capturing attention with its innovative superapp platform across Southeast Asia. With a market capitalization of $17.21 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds